A Deep-Seated Lipomatous Tumor of the Thigh Mimicking Lipoma: A Case Report of Atypical Lipomatous Tumor/Well Differentiated Liposarcoma Confirmed by MDM2 Gene Amplification

Authors

  • paramet khokhajaikiat -โรงพยาบาลนครพนม

Keywords:

มะเร็งเนื้อเยื่อไขมันชนิดเซลล์แบ่งตัวต่ำและรูปร่างเซลล์ยังไม่เปลี่ยนแปลงผิดปกติมาก, การเพิ่มจำนวนสำเนาของยีน MDM2, , เนื้องอกไขมันธรรมดาที่อยู่ลึกกว่าชั้นผิวหนังปกติ, , เทคนิคการตรวจหาตำแหน่งของยีนโดยใช้ฟลูออเรสเซนต์

Abstract

Objective: To report a rare case of deep-seated atypical lipomatous tumor/well-differentiated liposarcoma (ALT/WDLPS) of the thigh mimicking an ordinary lipoma, and to highlight the diagnostic value of MDM2 gene amplification via FISH in establishing a definitive diagnosis.

Methods: This is a qualitative case report of a 69-year-old Thai female presenting with a large, painless mass in the right thigh. Patient evaluation included physical examination, MRI, complete surgical excision, histopathological examination, and molecular analysis using FISH to detect MDM2 gene amplification.

Results: Physical examination revealed a soft, painless mass approximately 10 cm in size on the right thigh. MRI demonstrated a well-defined lesion measuring 4.6x7.2x16.7 cm within the right vastus lateralis muscle. Complete surgical resection was performed (specimen weighs 552.5 g, dimensions 13x8x2.5 cm). Histopathology revealed mature-appearing adipocytes infiltrating striated muscle, rendering ALT/WDLPS indistinguishable from a deep lipoma based on histology alone. FISH analysis demonstrated MDM2 gene amplification with an MDM2/CEP12 ratio of 8.5, confirming the diagnosis of ALT/WDLPS.

Conclusion: Deep-seated ALT/WDLPS closely resembles ordinary lipoma both clinically and histologically. Testing for MDM2 gene amplification via FISH is crucial for accurate differential diagnosis, particularly in patients over 50 years with deep-seated limb masses exceeding 10 cm

References

1. Nathani PB, Patel SM, Dholariya MV, Chothani M. A case report on rare case of left thigh recurrent liposarcoma. Int Surg J. 2024;11(9):1563-5.

2. Fletcher RH, Fletcher SW, Wagner EH. Clinical epidemiology: the essentials. 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 1996.

3. Pilotti S, Della Torre G, Mezzelani A, Tamborini E, Azzarelli A, Sozzi G, et al. The expression of MDM2/CDK4 gene product in the differential diagnosis of well differentiated liposarcoma and large deep-seated lipoma. Br J Cancer. 2000;82(7):1271-5.

4. Rosai J, Ackerman LV. Ackerman's surgical pathology. Vol. 1. 8th ed. Rosai J, editor. St. Louis: Mosby; 1996.

5. Piperi E, Tosios KI, Nikitakis NG, Kyriakopoulos VF, Tzerbos F, Koutlas IG, et al. Well-differentiated liposarcoma/atypical lipomatous tumor of the oral cavity: report of three cases and review of the literature. Head Neck Pathol. 2012;6(3):354-63.

6. Sciot R. MDM2 amplified sarcomas: a literature review. Diagnostics (Basel). 2021;11(3):496.

7. Nomura K, Tomita M, Kuroda K, Souda M, Chiba K, Yonekura A, et al. Overdiagnosis of atypical lipomatous tumors/well-differentiated liposarcomas by morphological diagnosis using only HE stained specimens: a case-control study with MDM2/CDK4 immunostaining and MDM2/CDK4 fluorescence in situ hybridization. BMC Cancer. 2024;24(1):1437.

8. Kim YC, Ryu S, Won SJ, Park JJ. Atypical lipomatous tumor/well-differentiated liposarcoma arising from the tongue: case report. Kosin Med J. 2020;35(1):58-63.

9. Kito M, Yoshimura Y, Isobe K, Takahashi V, Kato H, Nishida Y. Clinical outcome of deep-seated atypical lipomatous tumor of the extremities with median-term follow-up study. Eur J Surg Oncol. 2015;41(3):400-6.

10. Kalimuthu SN, Tilley C, Forbes G, Ye H, Lehovsky K, Pillay N, et al. Clinical outcome in patients with peripherally-sited atypical lipomatous tumours and dedifferentiated liposarcoma. J Pathol Clin Res. 2015;1(2):106-12.

11. Noebauer-Huhmann IM, Vilanova JC, Papakonstantinou O, Afonso PD, Bazzochi A, Bruguera J, et al. Soft tissue tumor imaging in adults: European Society of Musculoskeletal Radiology-Guidelines 2024: imaging immediately after neoadjuvant therapy in soft tissue sarcoma, soft tissue tumor surveillance, and the role of interventional radiology. Eur Radiol. 2025;35(6):3324-35.

12. Weschenfelder W, Koeglmeier KL, Weschenfelder F. Atypical lipomatous tumours vs. lipomas: A multimodal diagnostic approach. Diagnostics (Basel). 2025;15(12):1538.

13. Weaver J, Downs-Kelly E, Goldblum JR, Turner S, Kaelin C, Skacel M, et al. Fluorescence in situ hybridization for MDM2 gene amplification as a diagnostic tool in lipomatous neoplasms. Mod Pathol. 2008;21(8):943-9.

14. Fisher SB, Baxter KJ, Staley CA 3rd, Goel HS, Baisden BL, Monson DK, et al. The general surgeon's quandary: atypical lipomatous tumor vs lipoma, who needs a surgical oncologist? J Am Coll Surg. 2013;217(5):881-8.

15. Merino-Rueda LR, Casas-Ramos P, Honrado-Franco E, Izquierdo-García FM. Comparative study of deep lipomas and atypical lipomatous tumours: malignancy risk factors. Rev Esp Cir Ortop Traumatol. 2024;68(2):T383-9.

16. Brisson M, Kashima T, Delaney D, Tirabosco R, Clarke A, Cro S, et al. MRI characteristics of lipoma and atypical lipomatous tumor/well-differentiated liposarcoma: retrospective comparison with histology and MDM2 gene amplification. Skeletal Radiol. 2013;42(5):635-47.

Downloads

Published

2026-11-16

How to Cite

1.
khokhajaikiat paramet. A Deep-Seated Lipomatous Tumor of the Thigh Mimicking Lipoma: A Case Report of Atypical Lipomatous Tumor/Well Differentiated Liposarcoma Confirmed by MDM2 Gene Amplification. Nakhonphanom Hosp J [Internet]. 2026 Nov. 16 [cited 2026 Nov. 17];13(3):E290790. Available from: https://he01.tci-thaijo.org/index.php/nkpjournal_9/article/view/290790